Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
Sponsor: Julie Dawson
Summary
This is a single center, retrospective, observational cohort study to assess the safety and efficacy of drug coated balloon (DCB) angioplasty in all forms of coronary artery disease. The Investigators intend to report outcomes of all patients who received DCB angioplasty at their center during the above mentioned period for up to 10 years.
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2017-09-11
Completion Date
2027-01-31
Last Updated
2023-12-19
Healthy Volunteers
Not specified
Conditions
Interventions
Drug coated balloon angioplasty
Drug coated balloons are semi compliant percutaneous coronary angioplasty balloons coated with a chemotherapeutic drug such as Paclitaxel used with an excipient which allows rapid absorption to vessel wall upon balloon expansion for 30-60s. This allows coronary angioplasty without any permanent or semi- permanent stent or scaffold provided there are no vessel threatening dissections or significant acute recoil.
Locations (1)
Norfolk and Norwich University Hospital
Norwich, Norfolk, United Kingdom